Trial Condition(s):

Erectile Dysfunction

Evaluating of the efficacy and safety of Vardenafil in subjects with erectile dysfunction

Bayer Identifier:

100578

ClinicalTrials.gov Identifier:

NCT00662441

EudraCT Number:

Not Available

Study Completed

Trial Purpose

Erectile dysfunction (ED) is defined as the inability to achieve or maintain an erection sufficient for satisfactory sexual performance. An ideal treatment option should be effective and reliable, have minimal side effects, be simple to use and affordable. The purpose was the evaluation of efficacy and safety of 10 mg oral Vardenafil in Nigerian subjects with Erectile Dysfunction (ED).

Inclusion Criteria
- Men >/= 18 years of age
 - Erectile Dysfunction
Exclusion Criteria
- History of myocardial infarction, stroke or life-threatening arrhythmia within prior 6 month
 - Nitrate therapy
 - Other exclusion criteria apply according to the Summary of Product Characteristics

Trial Summary

Enrollment Goal
102
Trial Dates
black-arrow
Phase
4
Could I receive a placebo?
No
Products
Levitra (Vardenafil, BAY38-9456)
Accepts Healthy Volunteers
No

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Investigative Site

Many locations, Nigeria

Status
Completed
 

Trial Design